0001144204-17-065712.txt : 20171229
0001144204-17-065712.hdr.sgml : 20171229
20171229073701
ACCESSION NUMBER: 0001144204-17-065712
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171222
FILED AS OF DATE: 20171229
DATE AS OF CHANGE: 20171229
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: VF Strategic Equities Fund
CENTRAL INDEX KEY: 0001679283
STATE OF INCORPORATION: C3
FISCAL YEAR END: 0630
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-52607
FILM NUMBER: 171279777
BUSINESS ADDRESS:
STREET 1: 31 CARRINGTON STREET
CITY: NEDLANDS
STATE: C3
ZIP: 6009
BUSINESS PHONE: 61 (0)8 6430 9852
MAIL ADDRESS:
STREET 1: 31 CARRINGTON STREET
CITY: NEDLANDS
STATE: C3
ZIP: 6009
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UNIVERSAL BIOSENSORS INC
CENTRAL INDEX KEY: 0001279695
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 980424072
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 1 CORPORATE AVENUE
STREET 2: ROWVILLE
CITY: VICTORIA
STATE: C3
ZIP: 3178
BUSINESS PHONE: 613-9213-9000
MAIL ADDRESS:
STREET 1: 1 CORPORATE AVENUE
STREET 2: ROWVILLE
CITY: VICTORIA
STATE: C3
ZIP: 3178
4
1
tv482297_4.xml
OWNERSHIP DOCUMENT
X0306
4
2017-12-22
0
0001279695
UNIVERSAL BIOSENSORS INC
UBI
0001679283
VF Strategic Equities Fund
31 CARRINGTON STREET
NEDLANDS
C3
6009
AUSTRALIA
0
0
1
0
Common Stock
2017-12-22
4
P
0
100838
0.269
A
17520838
D
Common Stock
2017-12-27
4
P
0
168737
0.289
A
17689575
D
Common Stock
2017-12-28
4
P
0
151124
0.294
A
17840699
D
Common Stock
2017-12-29
4
P
0
2250953
0.300
A
20091652
D
Traded as Chess Depository Interests ("CDIs") on the Australian Stock Exchange. CDIs represent beneficial interests in the common stock held by CHESS Depository Nominees Pty Ltd.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.265 to $0.270, inclusive. The Reporting Person undertakes to provide to Universal Biosensors, Inc. ("UBI"), any security holder of UBI, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.275 to $0.300, inclusive. The Reporting Person undertakes to provide to Universal Biosensors, Inc. ("UBI"), any security holder of UBI, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.290 to $0.300, inclusive. The Reporting Person undertakes to provide to Universal Biosensors, Inc. ("UBI"), any security holder of UBI, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions all at a price of $0.300. The Reporting Person undertakes to provide to Universal Biosensors, Inc. ("UBI"), any security holder of UBI, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (5) to this Form 4.
The price per share of the common stock reported is stated in Australian dollars, as converted from a U.S. dollar price on the date of the transaction.
The common stock is directly held by VF Strategic Equities Fund ("Strategic Fund") and indirectly held by Viburnum Funds Pty Ltd ("Viburnum"), the manager of Strategic Fund, and the individual directors of Viburnum (Viburnum and the individual directors together, the "Viburnum Indirect Reporting Persons"). The individual directors of Viburnum are Craig Coleman, Marshall Allen, Anthony Howarth and Melissa Karlson. The Viburnum Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the Strategic Fund common stock in which the Viburnum Indirect Reporting Persons have no pecuniary interest.
/s/ David St. Quintin, as attorney-in-fact for VF Strategic Equities Fund and Viburnum Funds Pty Ltd
2017-12-29